Infectious disease testing: Key market research findings
- Initiatives by USAMRIID
- Demand for automated medical devices
Technavio has released a new market research report on the infectious disease testing market in the US, which is expected to grow at a CAGR of around 6% between 2016 and 2020. Increased use of rapid diagnostic tests for disease detection and screening is driving the growth of infectious disease testing market in the US. This has pushed manufacturers to sell a high volume of consumables such as assays, reagents, test strips, and polymerase chain reaction (PCR) plates.
The new industry research report from Technavio discusses in detail the key drivers and trends responsible for the growth of this market and its sub-segments.
“The US Army Medical Research Institute in Diagnostics and Development (USAMRIID) is making huge investments in research activities to develop diagnostics, drugs, and vaccines for infectious diseases to protect the members of the military from biological threats. The Department of Defence has an acquisition program, which includes design, engineering, test evaluation, production, operation, and support of defence systems. The Biomedical Advanced Research and Development Authority (BARDA) funds the purchase of vaccines for infectious diseases. The BARDA recently funded projects related to Ebola,” says Brahadeesh Chandrasekaran, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
The market is witnessing high demand for automated medical devices, owing to the growing volume of insured patients. These under-policy cover patients prefer the rapid automated equipment for tests in laboratories as these are more efficient and time-savvy. Manufacturers are coming up with point-of-care (POC) infectious disease diagnostic tests that give rapid results and immediate treatment decisions.
The key vendors in the infectious disease testing market in the US include Alere, Roche Diagnostics, Abbott Diagnostics, Siemens Healthcare, and Beckman Coulter Diagnostics. This market is highly fragmented with the presence of several large-, medium-, and small-sized manufacturers. The manufacturers are investing in the development of new products, owing to the growing demand for rapid diagnostics.
A more detailed analysis is available in the Technavio report, Infectious Disease Testing Market in the US 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
